Federation des caisses Desjardins du Quebec’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q3 | – | Sell |
-4,207
| Closed | -$772K | – | 2652 |
|
2021
Q2 | $772K | Sell |
4,207
-3,120
| -43% | -$573K | 0.01% | 771 |
|
2021
Q1 | $1.12M | Sell |
7,327
-100,336
| -93% | -$15.3M | 0.01% | 655 |
|
2020
Q4 | $16.8M | Buy |
107,663
+16,311
| +18% | +$2.55M | 0.2% | 102 |
|
2020
Q3 | $10.5M | Buy |
91,352
+2,053
| +2% | +$235K | 0.15% | 138 |
|
2020
Q2 | $10M | Buy |
89,299
+2,909
| +3% | +$327K | 0.15% | 132 |
|
2020
Q1 | $7.76M | Sell |
86,390
-24
| -0% | -$2.16K | 0.14% | 131 |
|
2019
Q4 | $9.35M | Buy |
86,414
+1,350
| +2% | +$146K | 0.13% | 128 |
|
2019
Q3 | $8.33M | Sell |
85,064
-662
| -0.8% | -$64.8K | 0.12% | 146 |
|
2019
Q2 | $11.2M | Sell |
85,726
-33
| -0% | -$4.32K | 0.17% | 108 |
|
2019
Q1 | $11.6M | Buy |
85,759
+4,428
| +5% | +$599K | 0.18% | 102 |
|
2018
Q4 | $7.92M | Sell |
81,331
-1,219
| -1% | -$119K | 0.13% | 135 |
|
2018
Q3 | $11.5M | Buy |
82,550
+5,448
| +7% | +$757K | 0.17% | 110 |
|
2018
Q2 | $9.57M | Buy |
77,102
+77,000
| +75,490% | +$9.56M | 0.14% | 122 |
|
2018
Q1 | $11.4K | Sell |
102
-373
| -79% | -$41.6K | ﹤0.01% | 1681 |
|
2017
Q4 | $56.8K | Buy |
475
+25
| +6% | +$2.99K | ﹤0.01% | 1303 |
|
2017
Q3 | $63.1K | Buy |
450
+50
| +13% | +$7.02K | ﹤0.01% | 1263 |
|
2017
Q2 | $48.7K | Buy |
+400
| New | +$48.7K | ﹤0.01% | 1382 |
|